BioInvent International AB (BINV) is traded on Stockholm Stock Exchange in Sweden. It is located in The Gamma Building and employs 56 people. The company currently falls under 'Small-Cap' category with current market capitalization of 588.67 M. BioInvent International AB operates under Healthcare
sector and is part of Pharmaceuticals And Biosciences
industry. This company has 304.7 M outstanding shares.
BIOINVENT has accumulated about 133.76 M in cash with (75.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check BioInvent International Probability Of Bankruptcy